SEC Filing Summary for Entera Bio Ltd.

On July 14, 2026, Jayne Miranda Toledano, Chief Executive Officer and Director of Entera Bio Ltd., received a grant of stock-settled restricted stock units (RSUs). This grant was approved by the Board of Directors on May 7, 2026, and subsequently by the shareholders on July 14, 2026. The RSUs were awarded in lieu of Toledano's 2025 annual cash bonus and $100,000 of her 2026 base salary. The RSUs vest quarterly over one year, starting May 1, 2026, with full acceleration upon a Change in Control. In total, 347,567 shares and 72,993 shares were granted, bringing the post-transaction ownership to 774,142 and 847,135 shares respectively. The transactions are marked as direct ownership and acquired shares with a price of $0.00.